Press Releases

FARMINGTON, Conn., March 20, 2020 /PRNewswire/ -- ImStem Biotechnology, Inc. (Farmington CT), a biopharmaceutical company pioneering the development of human embryonic stem cell (ESC) derived mesenchymal stem cells (hES-MSC), through a proprietary method using a trophoblast intermediate stage (hence also known as T-MSC) for the trea

PHOENIX, March 20, 2020 /PRNewswire/ -- What if you had a fully owned, fully functioning cut and sew factory—and you wanted to help produce not only mattresses, but also masks to help fight the pandemic—but you couldn't get through to the right government officials? Systems are, after all, overwhelmed.

WASHINGTON, March 20, 2020 /PRNewswire/ -- The National Federation of the Blind, America's civil rights organization of the blind, today expressed its absolute opposition to any proposal in COVID-19 emergency legislation, or any other legislative or regulatory action, that would undermine the rights of blind students and other students with disabilities under the Indivi

KANSAS CITY, March 20, 2020 /PRNewswire/ -- "We've been busy answering the concerns of companies and individuals throughout the Kansas City region," says Don McNulty, information and safety director at Kansas City-based Crime Scene Cleaners. "The built environment – wh

Key 2019 Events: $114.4 million aggregate gross proceeds were raised through a combination of a private placement offering of our common shares, followed by an equity rights offering   Listing of common shares on the Nasdaq Global Market ("Nasdaq") completed in the fourth quarter Divestiture of Prometic Bioseparations Limited ("PBL"), our affinity c

LAVAL, QC and CAMBRIDGE, United Kingdom, March 20, 2020 /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel treatments for patients suffering from diseases related to fibros

CORK, Ireland, March 20, 2020 /PRNewswire/ -- Today Johnson Controls Chairman and CEO, George Oliver, reaffirmed that the Company is delivering 'essential products, services, and personnel' during the COVID-19 pandemic. "At times like these, it is critically important to reach out and let people know that we are here and that we continue t

OMAHA, Neb., March 20, 2020 /PRNewswire/ -- Banyan Medical Systems, a next generation healthcare services delivery and technology company, today announces its Telehealth Aid Program

RIDGEFIELD, Conn. and INDIANAPOLIS, March 20, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued a complete response letter for the supplemental New Drug Application (sNDA) of the investigational medicine empagliflozin 2.5 mg as an adjunct to insulin for adults with type 1 diabetes. Empagliflozin 2.5 mg is being developed by Boehringer Ingelheim and Eli Lill

BERKELEY, Calif., March 20, 2020 /PRNewswire/ -- In an effort to quickly support fast-emerging public health needs and inequities resulting from the COVID-19 pandemic, the CARESTAR